Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06062017 · ClinicalTrials.gov registry record · NA

Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)

A NA study of Blood Pressure and Hydration, sponsored by Auburn University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06062017 is a NA study of Blood Pressure and Hydration that is actively recruiting participants, run by Auburn University. The registered enrollment target is 40 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06062017, a NA study of Blood Pressure and Hydration, is actively recruiting participants, sponsored by Auburn University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Compared with White Adults, Non-Hispanic Black Adults are at an elevated risk of developing cardiovascular disease (CVD) and end stage chronic-kidney disease (CKD), two of the leading causes of death in the United States. Inadequate hydration status is associated with risk factors for both CVD and CKD. Prior data show that Black individuals are less likely to be adequately hydrated when compared with their White counterparts. Further, socioeconomic factors have been shown to influence hydration practices. Inadequate hydration influences certain hormones that regulate blood volume and impact blood pressure, but increasing potassium intake may provide some positive effects on normalizing these hormones and blood pressure. Black adults, in particular, are more likely to consume less potassium, have inadequate hydration, and tend to have higher blood pressure. As such, there is a critical need for effective strategies to address racial disparities in hydration and resultant health consequences; as well as establish the role of socioeconomic factors contributing to hydration. Therefore, the investigators are seeking to test the investigators' central hypothesis that water with a potassium supplement will improve hydration and cardiovascular health in young White adults (n = 20, 10 females, 10 males), and to a greater extent in young Black Adults (n = 20, 10 females, 10 males. The investigators will assess measures of blood pressure, arterial stiffness, and biomarkers in the urine and blood samples prior to and following a 14-day hydration intervention of 1) bottled water and 2) bottled water with potassium supplementation (2000mg potassium/day).

Interventions

  • DIETARY_SUPPLEMENT Water and Potassium supplementation

Study Locations (1)

Alabama

  • Kinesiology Building - Auburn

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-11-06
Est. Completion 2027-07
Phase NA

Sponsor

Auburn University

54 total trials

What the Registry Record Tells You About NCT06062017

The ClinicalTrials.gov registry entry for NCT06062017 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Water and Potassium supplementation is the first listed.

NCT06062017 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06062017 about?

NCT06062017 is a clinical study titled "Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)". Compared with White Adults, Non-Hispanic Black Adults are at an elevated risk of developing cardiovascular disease (CVD) and end stage chronic-kidney disease (CKD), two of the leading causes of death in the United States. Inadequate hydration status is associated with risk factors for both CVD and C...

What is the current status of trial NCT06062017?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-11-06. Estimated completion is 2027-07.

What conditions does trial NCT06062017 study?

This clinical trial studies the following conditions: Blood Pressure, Hydration, Vascular Disease Risk.

What interventions are being tested in trial NCT06062017?

The interventions under investigation include: Water and Potassium supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06062017?

This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06062017 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.